Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170617034590N2Phase 3Completed
Phase 3, single-arm trial of sirolimus in port-wine stain, sponsored by Tehran University of Medical Sciences. Primary endpoint: Reduction in lesion erythema. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170617034590N2.